Concord, MA, United States of America

Cognoptix, Inc.


USPTO Granted Patents = 5

% Expired Patents = 100.0



Forward Citations = 52

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Paul D Hartung (5 out of 6 patents)

silverMedal Gerald D Cagle (3 out of 21 patents)

bronzeMedal Vincent Valvo (3 out of 3 patents)

4.  Dennis J Nilan (3 out of 3 patents)

5.  Charles Kerbage (2 out of 2 patents)

6.  Francis X Smith (1 out of 32 patents)

7.  Evan Sherr (1 out of 8 patents)

8.  Leo T Chylack, Jr (1 out of 8 patents)

9.  Norman C Ford (1 out of 11 patents)

10.  Lee E Goldstein (1 out of 9 patents)

11.  Marc David Friedman (1 out of 43 patents)

12.  Haresh G Bhagat (1 out of 11 patents)

13.  Stephen D Fantone (1 out of 69 patents)

14.  Steven D Fantone (1 patent)

15.  Leo T Chylack (0 patent)


5 patents:

Company Overview
Cognoptix, Inc. is a medical technology company that is revolutionizing the way cognitive impairment and Alzheimer's disease are detected and treated. Their innovative ophthalmic system, known as the SAPPHIRE II System, uses a non-invasive eye scan to detect early signs of Alzheimer's by measuring beta-amyloid in the eye lens. This breakthrough technology has the potential to enable early intervention and improve patient outcomes in the fight against Alzheimer's disease.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#25 in Concord, MA

#2,894 in Massachusetts

#51,644 in US

Concord, MA (US)
Concord, MA, United States of America
Forward Citations = 52

13 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cognoptix, Inc.. Retrieved from https://idiyas.com/company/cognoptix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…